Future of local bone regeneration - Protein versus gene therapy

Journal of Cranio-Maxillofacial Surgery

Volumn 39, Issue 1, 2011, Pages 54-64

  Fischer, J ^a   Kolk, A ^b   Wolfart, St ^a   Pautke, C ^b   Warnke, P H ^c,d   Plank, C ^b   Smeets, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d BOND UNIVERSITY   (Australia)

Author keywords

Bone morphogenic protein; Bone regeneration; Drug delivery; Gene transfer; Nanotechnology

Indexed keywords

ADENOVIRUS VECTOR; ANTIGEN; BASIC FIBROBLAST GROWTH FACTOR; BIOCERAMICS; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCIUM PHOSPHATE; CHORDIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRIN; GROWTH FACTOR; HETERODIMER; HYDROXYAPATITE; NOGGIN; NONCOLLAGENOUS PROTEIN; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PLASMID VECTOR; PLATELET DERIVED GROWTH FACTOR; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; SOMATOMEDIN; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; BIOREACTOR; BONE MATRIX; BONE MINERAL; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA TRANSFER; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HEALTH HAZARD; HERPES VIRUS SAIMIRI; HUMAN; HYDROGEL; INFECTION RISK; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSSIFICATION; RETROVIRUS; REVIEW; RISK BENEFIT ANALYSIS; TARGET CELL; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRUS TRANSMISSION;

BONE REGENERATION; DRUG DELIVERY SYSTEMS; FORECASTING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TISSUE ENGINEERING;

EID: 78149359717     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2010.03.016     Document Type: Review

References (137)

1. E. Alsberg, E.E. Hill, and D.J. Mooney Craniofacial tissue engineering Crit Rev Oral Biol Med 12 2001 64 75
2. W.F. Anderson Human gene therapy Nature 392 1998 25 30
3. T. Asahara, C. Kalka, and J.M. Isner Stem cell therapy and gene transfer for regeneration Gene Ther 7 2000 451 457
4. I. Asahina, M. Watanabe, N. Sakurai, M. Mori, and S. Enomoto Repair of bone defect in primate mandible using a bone morphogenetic protein (BMP)-hydroxyapatite-collagen composite J Med Dent Sci 44 1997 63 70
5. A.W. Baltzer, C. Lattermann, J.D. Whalen, P. Wooley, K. Weiss, and M. Grimm Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene Gene Ther 7 2000 734 739
6. P. Bianco, and P.G. Robey Stem cells in tissue engineering Nature 414 2001 118 121
7. J.S. Blum, M.A. Barry, A.G. Mikos, and J.A. Jansen In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model Hum Gene Ther 14 2003 1689 1701
8. S.D. Boden, G.J. Martin Jr., M.A. Morone, J.L. Ugbo, and P.A. Moskovitz Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate Spine 24 1999 1179 1185
9. J. Bonadio Tissue engineering via local gene delivery: update and future prospects for enhancing the technology Adv Drug Deliv Rev 44 2000 185 194
10. J. Bonadio Genetic approaches to tissue repair Ann N Y Acad Sci 961 2002 58 60
11. J. Bonadio, E. Smiley, P. Patil, and S. Goldstein Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration Nat Med 5 1999 753 759
12. P.J. Boyne, R.E. Marx, M. Nevins, G. Triplett, E. Lazaro, and L.C. Lilly A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation Int J Periodontics Restorative Dent 17 1997 11 25
13. A.S. Breitbart, D.A. Grande, J.M. Mason, M. Barcia, T. James, and R.T. Grant Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene Ann Plast Surg 42 1999 488 495
14. M. Cavazzana-Calvo, S. Hacein-Bey, C.D. Basile, F. Gross, E. Yvon, and P. Nusbaum Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672 (Pubitemid 30241569)
15. A.J. Celeste, J.A. Iannazzi, R.C. Taylor, R.M. Hewick, V. Rosen, and E.A. Wang Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone Proc Natl Acad Sci U S A 87 1990 9843 9847
16. S.C. Chang, H.L. Chuang, Y.R. Chen, J.K. Chen, H.Y. Chung, and Y.L. Lu Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration Gene Ther 10 2003 2013 2019
17. Y. Chen, K.M. Cheung, H.F. Kung, J.C. Leong, W.W. Lu, and K.D. Luk In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene Biochem Biophys Res Commun 298 2002 121 127
18. Y. Chen, K.D. Luk, K.M. Cheung, R. Xu, M.C. Lin, and W.W. Lu Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors Gene Ther 10 2003 1345 1353 (Pubitemid 36987125)
19. J. Ciment Gene therapy experiments put on "clinical hold" BMJ 320 2000 336
20. T.M. Crombleholme Adenoviral-mediated gene transfer in wound healing Wound Repair Regen 8 2000 460 472
21. K.R. Dai, X.L. Xu, T.T. Tang, Z.A. Zhu, C.F. Yu, and J.R. Lou Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone Calcif Tissue Int 77 2005 55 61
22. J. De Groot Carriers that concentrate native bone morphogenetic protein in vivo Tissue Eng 4 1998 337 341
23. L. De Laporte, J. Cruz Rea, and L.D. Shea Design of modular non-viral gene therapy vectors Biomaterials 27 2006 947 954
24. L. De Laporte, and L.D. Shea Matrices and scaffolds for DNA delivery in tissue engineering Adv Drug Deliv Rev 59 2007 292 307
25. H. Deppe, and A. Stemberger Effects of laser-modified versus osteopromotively coated titanium membranes on bone healing: a pilot study in rat mandibular defects Lasers Med Sci 18 2004 190 195
26. H. Deppe, A. Stemberger, and M. Hillemanns Effects of osteopromotive and anti-infective membranes on bone regeneration: an experimental study in rat mandibular defects Int J Oral Maxillofac Implants 18 2003 369 376 (Pubitemid 37141332)
27. J.L. Dragoo, J.Y. Choi, J.R. Lieberman, J. Huang, P.A. Zuk, and J. Zhang Bone induction by BMP-2 transduced stem cells derived from human fat J Orthop Res 21 2003 622 629
28. P. Ducy, and G. Karsenty The family of bone morphogenetic proteins Kidney Int 57 2000 2207 2214
29. P. Ducy, R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Cell 89 1997 747 754
30. T.A. Einhorn Clinical applications of recombinant gene technology: bone and cartilage repair Cells Mat 2 1992 1 11
31. P.I. Eke, and R.J. Genco CDC periodontal disease surveillance project: background, objectives, and progress report J Periodontol 78 2007 1366 1371
32. C.H. Evans, and P.D. Robbins Possible orthopaedic applications of gene therapy J Bone Joint Surg Am 77 1995 1103 1114
33. J. Fang, Y.Y. Zhu, E. Smiley, J. Bonadio, J.P. Rouleau, and S.A. Goldstein Stimulation of new bone formation by direct transfer of osteogenic plasmid genes Proc Natl Acad Sci U S A 93 1996 5753 5758
34. H. Fechner, A. Haack, H. Wang, X. Wang, K. Eizema, and M. Pauschinger Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers Gene Ther 6 1999 1520 1535
35. R.T. Franceschi, D. Wang, P.H. Krebsbach, and R.B. Rutherford Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7 J Cell Biochem 78 2000 476 486
36. R.T. Franceschi, S. Yang, R.B. Rutherford, P.H. Krebsbach, M. Zhao, and D. Wang Gene therapy approaches for bone regeneration Cells Tissues Organs 176 2004 95 108
37. E.A. Frolova-Jones, A. Ensser, A.J. Stevenson, S.E. Kinsey, and D.M. Meredith Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors J Hematother Stem Cell Res 9 2000 573 581
38. T. Gao, T.S. Lindholm, A. Marttinen, and M.R. Urist Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics Int Orthop 20 1996 321 325
39. P.V. Giannoudis, T.A. Einhorn, and D. Marsh Fracture healing: the diamond concept Injury 38 Suppl. 4 2007 S3 S6
40. R. Gysin, J.E. Wergedal, M.H. Sheng, Y. Kasukawa, N. Miyakoshi, and S.T. Chen Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats Gene Ther 9 2002 991 999
41. S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, and E. McIntyre A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N Engl J Med 348 2003 255 256
42. S. Hardy, M. Kitamura, T. Harris-Stansil, Y. Dai, and M.L. Phipps Construction of adenovirus vectors through Cre-lox recombination J Virol 71 1997 1842 1849
43. D. Hartigan-O'Connor, A. Amalfitano, and J.S. Chamberlain Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase J Virol 73 1999 7835 7841
44. M. Havenga, P. Hoogerbrugge, D. Valerio, and H.H. van Es Retroviral stem cell gene therapy Stem Cells 15 1997 162 179
45. K. Hirata, T. Tsukazaki, A. Kadowaki, K. Furukawa, Y. Shibata, and T. Moriishi Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2 Bone 32 2003 502 512
46. J.O. Hollinger, and J.P. Schmitz Macrophysiologic roles of a delivery system for vulnerary factors needed for bone regeneration Ann N Y Acad Sci 831 1997 427 437
47. J.O. Hollinger, and S.R. Winn Tissue engineering of bone in the craniofacial complex Ann N Y Acad Sci 875 1999 379 385
48. Hollinger JO, Winn SR, Hu Y, Sipe R, Buck DC, Xi. G: Assembling a bone - regeneration therapy. In: Davies JE (ed.) Bone engineering. pp. 437-440, Toronto.
49. Y. Horisaka, Y. Okamoto, N. Matsumoto, Y. Yoshimura, J. Kawada, and K. Yamashita Subperiosteal implantation of bone morphogenetic protein adsorbed to hydroxyapatite Clin Orthop Relat Res 1991 303 312
50. T.H. Howell, J. Fiorellini, A. Jones, M. Alder, P. Nummikoski, and M. Lazaro A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation Int J Periodontics Restorative Dent 17 1997 124 139
51. Y.C. Huang, K. Riddle, K.G. Rice, and D.J. Mooney Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds Hum Gene Ther 16 2005 609 617
52. H. Ito, J.J. Goater, P. Tiyapatanaputi, P.T. Rubery, R.J. O'Keefe, and E.M. Schwarz Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells Gene Ther 11 2004 34 41
53. T. Ito, K. Tokunaga, H. Maruyama, H. Kawashima, H. Kitahara, and T. Horikoshi Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing Gene Ther 10 2003 1623 1628
54. J.A. Jane Jr., B.A. Dunford, A. Kron, D.D. Pittman, T. Sasaki, and J.Z. Li Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer Mol Ther 6 2002 464 470
55. D.D. Jenkins, G.P. Yang, H.P. Lorenz, M.T. Longaker, and K.G. Sylvester Tissue engineering and regenerative medicine Clin Plast Surg 30 2003 581 588
56. O. Jeon, S.J. Song, H.S. Yang, S.H. Bhang, S.W. Kang, and M.A. Sung Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery Biochem Biophys Res Commun 369 2008 774 780
57. Q.M. Jin, O. Anusaksathien, S.A. Webb, R.B. Rutherford, and W.V. Giannobile Gene therapy of bone morphogenetic protein for periodontal tissue engineering J Periodontol 74 2003 202 213
58. D. Kaigler, and D. Mooney Tissue engineering's impact on dentistry J Dent Educ 65 2001 456 462
59. M. Kawabata, T. Imamura, and K. Miyazono Signal transduction by bone morphogenetic proteins Cytokine Growth Factor Rev 9 1998 49 61 (Pubitemid 28280536)
60. C.A. Kirker-Head Potential applications and delivery strategies for bone morphogenetic proteins Adv Drug Deliv Rev 43 2000 65 92
61. N.A. Kootstra, and I.M. Verma Gene therapy with viral vectors Annu Rev Pharmacol Toxicol 43 2003 413 439
62. R. Langer Drug delivery and targeting Nature 392 1998 5 10
63. R. Langer, and J.P. Vacanti Tissue engineering Science 260 1993 920 926
64. J.Y. Lee, H. Peng, A. Usas, D. Musgrave, J. Cummins, and D. Pelinkovic Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2 Hum Gene Ther 13 2002 1201 1211
65. G. Li, K. Corsi-Payne, B. Zheng, A. Usas, H. Peng, and J. Huard The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation Tissue Eng Part A 2009
66. J.Z. Li, H. Li, T. Sasaki, D. Holman, B. Beres, and R.J. Dumont Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat Gene Ther 10 2003 1735 1743
67. J.R. Lieberman, M. Kono, E. Vertelney, G.A.M. Finerman, and O.N. Witte The creation of rhBMP-2 producing cell line: retroviral gene transfer of rhBMP-2 into a stromal line Trans. Orthop. Res. Soc. 41st Ann. Meeting vol. 20 1995 499
68. J.R. Lieberman, L.Q. Le, L. Wu, G.A. Finerman, A. Berk, and O.N. Witte Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents J Orthop Res 16 1998 330 339
69. K.D. Luk, Y. Chen, K.M. Cheung, H.F. Kung, W.W. Lu, and J.C. Leong Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation Biochem Biophys Res Commun 308 2003 636 645 (Pubitemid 36945540)
70. M.J. Lysaght, and J. Reyes The growth of tissue engineering Tissue Eng 7 2001 485 493
71. J.A. Mahr, and L.R. Gooding Immune evasion by adenoviruses Immunol Rev 168 1999 121 130
72. J.C. Marx, J.A. Allay, D.A. Persons, S.A. Nooner, P.W. Hargrove, and P.F. Kelly High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells Hum Gene Ther 10 1999 1163 1173
73. J.M. Mason, D.A. Grande, M. Barcia, R. Grant, R.G. Pergolizzi, and A.S. Breitbart Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair Gene Ther 5 1998 1098 1104
74. J.E. McCormack, D. Martineau, N. DePolo, S. Maifert, L. Akbarian, and K. Townsend Anti-vector immunoglobulin induced by retroviral vectors Hum Gene Ther 8 1997 1263 1273
75. D.G. Miller, M.A. Adam, and A.D. Miller Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection Mol Cell Biol 10 1990 4239 4242
76. Y. Miura, K. Yoshida, T. Nishimoto, K. Hatanaka, S. Ohnami, and M. Asaka Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob Gene Ther 14 2007 1448 1460
77. P.E. Monahan, and R.J. Samulski Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 6 2000 433 440
78. I.K. Moutsatsos, G. Turgeman, S. Zhou, B.G. Kurkalli, G. Pelled, and L. Tzur Exogenously regulated stem cell-mediated gene therapy for bone regeneration Mol Ther 3 2001 449 461
79. D.S. Musgrave, P. Bosch, S. Ghivizzani, P.D. Robbins, C.H. Evans, and J. Huard Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone Bone 24 1999 541 547
80. D.S. Musgrave, P. Bosch, J.Y. Lee, D. Pelinkovic, S.C. Ghivizzani, and J. Whalen Ex vivo gene therapy to produce bone using different cell types Clin Orthop Relat Res 2000 290 305
81. N. Muzyczka Use of adeno-associated virus as a general transduction vector for mammalian cells Curr Top Microbiol Immunol 158 1992 97 129
82. O. Mykhaylyk, Y.S. Antequera, D. Vlaskou, and C. Plank Generation of magnetic nonviral gene transfer agents and magnetofection in vitro Nat Protoc 2 2007 2391 2411
83. L.E. Niklason, and R. Langer Prospects for organ and tissue replacement JAMA 285 2001 573 576
84. P. Noguchi Risks and benefits of gene therapy N Engl J Med 348 2003 193 194
85. D.A. Oakes, and J.R. Lieberman Osteoinductive applications of regional gene therapy: ex vivo gene transfer Clin Orthop Relat Res 379 Suppl. 2000 S101 S112
86. R.J. Oringer Biological mediators for periodontal and bone regeneration Compend Contin Educ Dent 23 2002 501-504, 506-510, 512 passim; quiz 518
87. E. Ozkaynak, D.C. Rueger, E.A. Drier, C. Corbett, R.J. Ridge, and T.K. Sampath OP-1 cDNA encodes an osteogenic protein in the TGF-beta family Embo J 9 1990 2085 2093
88. D.W. Pack, A.S. Hoffman, S. Pun, and P.S. Stayton Design and development of polymers for gene delivery Nat Rev Drug Discov 4 2005 581 593
89. J. Park, J. Ries, K. Gelse, F. Kloss, K. von der Mark, and J. Wiltfang Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes Gene Ther 10 2003 1089 1098
90. H. Peng, V. Wright, A. Usas, B. Gearhart, H.C. Shen, J. Cummins, and J. Huard Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4 J Clin Invest 110 2002 751 759
91. C. Plank, M. Anton, C. Rudolph, J. Rosenecker, and F. Krotz Enhancing and targeting nucleic acid delivery by magnetic force Expert Opin Biol Ther 3 2003 745 758
92. C. Plank, F. Scherer, U. Schillinger, C. Bergemann, and M. Anton Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields J Liposome Res 13 2003 29 32
93. C. Plank, U. Schillinger, F. Scherer, C. Bergemann, J.S. Remy, and F. Krotz The magnetofection method: using magnetic force to enhance gene delivery Biol Chem 384 2003 737 747
94. D. Putnam, and A. Doody RNA-interference effectors and their delivery Crit Rev Ther Drug Carrier Syst 23 2006 137 164
95. J.E. Rabinowitz, and J. Samulski Adeno-associated virus expression systems for gene transfer Curr Opin Biotechnol 9 1998 470 475
96. A.H. Reddi Regulation of cartilage and bone differentiation by bone morphogenetic proteins Curr Opin Cell Biol 4 1992 850 855
97. U. Ripamonti, and N. Duneas Tissue morphogenesis and regeneration by bone morphogenetic proteins Plast Reconstr Surg 101 1998 227 239
98. U. Ripamonti, and A.H. Reddi Periodontal regeneration: potential role of bone morphogenetic proteins J Periodontal Res 29 1994 225 235
99. U. Ripamonti, and A.H. Reddi Tissue engineering, morphogenesis, and regeneration of the periodontal tissues by bone morphogenetic proteins Crit Rev Oral Biol Med 8 1997 154 163
100. C.M. Roth, and S. Sundaram Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways Annu Rev Biomed Eng 6 2004 397 426
101. C.H. Rundle, N. Miyakoshi, Y. Kasukawa, S.T. Chen, M.H. Sheng, and J.E. Wergedal In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4 Bone 32 2003 591 601
102. R.B. Rutherford, M. Moalli, R.T. Franceschi, D. Wang, K. Gu, and P.H. Krebsbach Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo Tissue Eng 8 2002 441 452
103. G. Sailaja, H. HogenEsch, A. North, J. Hays, and S.K. Mittal Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response Gene Ther 9 2002 1722 1729
104. A.A. Scaduto, and J.R. Lieberman Gene therapy for osteoinduction Orthop Clin North Am 30 1999 625 633
105. R.M. Schek, S.J. Hollister, and P.H. Krebsbach Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy Mol Ther 9 2004 130 138
106. H. Schliephake, A. Aref, D. Scharnweber, S. Bierbaum, S. Roessler, and A. Sewing Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation Clin Oral Implants Res 16 2005 563 569
107. G. Schmidmaier, P. Schwabe, B. Wildemann, and N.P. Haas Use of bone morphogenetic proteins for treatment of non-unions and future perspectives Injury 4 38 Suppl. 2007 S35 S41
108. G. Schmidmaier, B. Wildemann, T. Gabelein, J. Heeger, F. Kandziora, and N.P. Haas Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1 Acta Orthop Scand 74 2003 604 610
109. G. Schmidmaier, B. Wildemann, J. Heeger, T. Gabelein, A. Flyvbjerg, and H.J. Bail Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1 Bone 31 2002 165 172
110. H. Seeherman, J. Wozney, and R. Li Bone morphogenetic protein delivery systems Spine 27 2002 S16 S23
111. Y. Shou, Z. Ma, T. Lu, and B.P. Sorrentino Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy Proc Natl Acad Sci U S A 103 2006 11730 11735
112. T.J. Sigurdsson, L. Nygaard, D.N. Tatakis, E. Fu, T.J. Turek, and L. Jin Periodontal repair in dogs: evaluation of rhBMP-2 carriers Int J Periodontics Restorative Dent 16 1996 524 537
113. R. Smeets, O. Maciejewski, M. Gerressen, H. Spiekermann, O. Hanisch, and D. Riediger Impact of rhBMP-2 on regeneration of buccal alveolar defects during the osseointegration of transgingival inserted implants Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 2009 e3 e12
114. S. Spagnou, A.D. Miller, and M. Keller Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA Biochemistry 43 2004 13348 13356
115. H. Storrie, and D.J. Mooney Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering Adv Drug Deliv Rev 58 2006 500 514
116. N. Sykaras, and L.A. Opperman Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J Oral Sci 45 2003 57 73
117. D.C. Tancred, A.J. Carr, and B.A. McCormack Development of a new synthetic bone graft J Mater Sci Mater Med 9 1998 819 823
118. O.M. Tepper, and B.J. Mehrara Gene therapy in plastic surgery Plast Reconstr Surg 109 2002 716 734
119. H. Terheyden, P. Warnke, A. Dunsche, S. Jepsen, W. Brenner, and S. Palmie Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part II: transplantation Int J Oral Maxillofac Surg 30 2001 469 478
120. T.G. Terrell, P.K. Working, C.P. Chow, and J.D. Green Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits Int Rev Exp Pathol 34 Pt B 1993 43 67
121. P. Ueblacker, B. Wagner, S. Vogt, G. Salzmann, G. Wexel, and A. Kruger In vivo analysis of retroviral gene transfer to chondrocytes within collagen scaffolds for the treatment of osteochondral defects Biomaterials 28 2007 4480 4487
122. H. Uludag, W. Friess, D. Williams, T. Porter, G. Timony, and D. D'Augusta rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics Ann N Y Acad Sci 875 1999 369 378
123. M.R. Urist Bone: formation by autoinduction Science 150 1965 893 899
124. S. Vogt, P. Ueblacker, C. Geis, B. Wagner, G. Wexel, and T. Tischer Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector Biomaterials 29 2008 1242 1249
125. E.A. Wang Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects Trends Biotechnol 11 1993 379 383
126. E.A. Wang, V. Rosen, P. Cordes, R.M. Hewick, M.J. Kriz, and D.P. Luxenberg Purification and characterization of other distinct bone-inducing factors Proc Natl Acad Sci U S A 85 1988 9484 9488
127. E.A. Wang, V. Rosen, J.S. D'Alessandro, M. Bauduy, P. Cordes, and T. Harada Recombinant human bone morphogenetic protein induces bone formation Proc Natl Acad Sci U S A 87 1990 2220 2224
128. P.H. Warnke, I.N. Springer, Y. Acil, G. Julga, J. Wiltfang, and K. Ludwig The mechanical integrity of in vivo engineered heterotopic bone Biomaterials 27 2006 1081 1087
129. P.H. Warnke, I.N. Springer, J. Wiltfang, Y. Acil, H. Eufinger, and M. Wehmoller Growth and transplantation of a custom vascularised bone graft in a man Lancet 364 2004 766 770
130. C.M. Wiethoff, and C.R. Middaugh Barriers to nonviral gene delivery J Pharm Sci 92 2003 203 217
131. H. Winet, and J.O. Hollinger Incorporation of polylactide-polyglycolide in a cortical defect: neoosteogenesis in a bone chamber J Biomed Mater Res 27 1993 667 676
132. S.R. Winn, H. Uludag, and J.O. Hollinger Carrier systems for bone morphogenetic proteins Clin Orthop Relat Res 367 Suppl. 1999 S95 S106
133. J.M. Wozney The bone morphogenetic protein family and osteogenesis Mol Reprod Dev 32 1992 160 167
134. J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, and R.W. Kriz Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534
135. S. Yang, D. Wei, D. Wang, M. Phimphilai, P.H. Krebsbach, and R.T. Franceschi In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation J Bone Miner Res 18 2003 705 715
136. X. Zhang, and W.T. Godbey Viral vectors for gene delivery in tissue engineering Adv Drug Deliv Rev 58 2006 515 534 (Pubitemid 43928170)
137. M. Zhao, Z. Zhao, J.T. Koh, T. Jin, and R.T. Franceschi Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7 J Cell Biochem 95 2005 1 16